Asia Pacific Myomectomy Market By Type (Abdominal Myomectomy, Hysteroscopic Myomectomy and Laparoscopic Myomectomy), By Product (Harmonic Scalpel, Laparoscopic Sealer, Laparoscopic Power Morcellators and Other Products), By Country, Industry Analysis and Forecast, 2020 - 2026

The Asia Pacific Myomectomy Market is expected to witness market growth of 15.2% CAGR during the forecast period (2020-2026).

The introduction of technologically advanced products in the market due to the more adoption of myomectomy procedures for the removal of uterine fibroids is expected to boost the growth of the market. Advancements in technology and its increased implementation in healthcare industries, for example, the introduction of robotically assisted myomectomy procedures which is an incision-less surgery and has minimal side effects that is why it is widely used for fibroids treatment. As compared to the open abdominal myomectomy surgery, with that of robotic myomectomy, it is proved that patient experience less blood loss and also has fewer complication rates, patients also need to have a shorter hospital stay and resume normal activities more quickly.

Therefore, the use of robotics for myomectomy surgery is accompanied with several advantages over the normal open laparoscopy surgery, that is why robotics with myomectomy is widely have been widely accepted and integrated in the field of reproductive surgery. Therefore, the key market players include Medtronic; Stryker Corporation; CONMED Corporation; Intuitive Surgical; Johnson and Johnson Services, Inc.; and Minerva Surgical, Inc. These main players are involved in widespread R&D exercises in order to produce advanced products and they are putting a constant effort for presenting technologically more advanced products in the market. This is likely to boost the market in the coming years.

Moreover, a rise in the number of patients who prefer non-invasive treatment is anticipated to drive the market growth during the foreseeable period. In recent times, numerous minimal/non-invasive myomectomy techniques have been introduced by the manufacturing companies into the market that is capable of destroying fibroids efficiently and preserve the normal functioning of the uterus for future pregnancy. Currently, non or less invasive treatments like laparoscopic, or robotically-assisted myomectomy procedures that are technologically advanced devices are been favored as a choice of fibroid treatment options among women.

Based on Type, the market is segmented into Abdominal Myomectomy, Hysteroscopic Myomectomy and Laparoscopic Myomectomy. Based on Product, the market is segmented into Harmonic Scalpel, Laparoscopic Sealer, Laparoscopic Power Morcellators and Other Products. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

The market research report covers theanalysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, Stryker Corporation, Johnson and Johnson, Hologic, Inc., Karl Storz SE & Co. KG, B. Braun Melsungen AG, ConMed Corporation, Intuitive Surgical, Inc., The Cooper Companies, Inc., and Minerva Surgical, Inc.

Scope of the Study

Market Segmentation:

By Type

• Abdominal Myomectomy
• Hysteroscopic Myomectomy
• Laparoscopic Myomectomy

By Product

• Harmonic Scalpel
• Laparoscopic Sealer
• Laparoscopic Power Morcellators
• Other Products

By Country

• China
• Japan
• India
• South Korea
• Singapore
• Malaysia
• Rest of Asia Pacific

Companies Profiled

• Medtronic PLC
• Stryker Corporation
• Johnson and Johnson
• Hologic, Inc.
• Karl Storz SE & Co. KG
• B. Braun Melsungen AG
• ConMed Corporation
• Intuitive Surgical, Inc.
• The Cooper Companies, Inc.
• Minerva Surgical, Inc.

Unique Offerings from the Publisher

• Exhaustive coverage
• Highest number of market tables and figures
• Subscription based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free